Quality-adjusted life years assessment using cabozantinib for patients with advanced hepatocellular carcinoma (aHCC) in the CELESTIAL trial Meeting Abstract
| Authors: | Abou-Alfa, G. K.; Mollon, P.; Meyer, T.; Cheng, A. L.; El-Khoueiry, A. B.; Kelley, R. K.; Baron, A. D.; Benzaghou, F.; Valcheva, V. V.; Hazra, S.; Mangeshkar, M.; Freemantle, N. |
| Abstract Title: | Quality-adjusted life years assessment using cabozantinib for patients with advanced hepatocellular carcinoma (aHCC) in the CELESTIAL trial |
| Meeting Title: | 2019 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2019 Jan 17-19 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-02-01 |
| Language: | English |
| ACCESSION: | WOS:000489107600240 |
| DOI: | 10.1200/JCO.2019.37.4_suppl.207 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 207 -- Source: Wos |
